ABSTRACT

Coronary stenting is the most commonly used method of myocardial revascularization, with approximately 2 million stents implanted in 2004 throughout the world. The development of drug eluting stents has resulted in very low rates of repeat intervention and will further increase the scope for percutaneous coronary intervention.The evidence from larg

chapter 1|8 pages

Immunoallergic syndromes in interventional cardiology

Chourmouzios A Arampatzis, Giannis Kanonidis, and Patrick W Serruys

chapter 2|18 pages

The kidney and percutaneous coronary interventions

ByEugenia Nikolsky, Alexander Abizaid, Roxana Mehran

chapter 3|12 pages

Treatment of coronary artery disease in diabetic patients

ByPilar Jiménez-Quevedo, Manel Sabaté Tenas

chapter 4|10 pages

Ad hoc percutaneous coronary intervention

ByFrancesco Saia, Federica Baldazzi, Antonio Marzocchi

chapter 5|16 pages

Dilemmas in non-ST elevation acute coronary syndromes

John A Ambrose, John T Coppola, and Henning Rasmussen

chapter 6|12 pages

Patients with impaired hemostasis requiring cardiac catheterization and coronary intervention

ByNicolai Mejevoi, Jean-Bernard Durand, Marc Cohen

chapter 7|10 pages

ST elevation acute myocardial infarction admitted in a distant location

ByMarc C Newell, David M Larson, Timothy D Henry

chapter 8|8 pages

Stable obstructive coronary disease and very low left ventricular function

ByPedro de Araújo Gonçalves and Ricardo Seabra-Gomes

chapter 12|18 pages

Percutaneous coronary intervention for patients with multivessel disease

ByAndrew TL Ong and Patrick W Serruys

chapter 13|10 pages

Highly complex anatomical morphologies: percutaneous intervention versus bypass surgery

ByLeonardo C Clavijo, Augusto Pichard

chapter 14|22 pages

Advanced atherosclerotic diseases in multiple vascular bed sites

Luis A Guzman and Theodore Bass

chapter 15|12 pages

The intermediate coronary lesion Pedro A Lemos, and Patrick W Serruys

Pedro A Lemos and Patrick W Serruys

chapter 16|6 pages

Percutaneous coronary intervention in the treatment of cardiogenic shock complicating acute myocardial infarction

ByExpedito Ribeiro, Pedro E Horta, Marcus N da Gama and Eulógio E Martinez

chapter 17|10 pages

The hypotensive patient after angioplasty: occult life-threatening percutaneous coronary intervention-related complications

Eulógio E Martinez, Marco A Perin, and Luiz J Kajita

chapter 18|12 pages

Percutaneous treatment for patients with end-stage aortic valve disease

ByAamer H Jamali, Raj R Makkar

chapter 20|10 pages

Septal ablation for hypertrophic cardiomyopathy: to whom, when, and how?

ByMuzaffer Degertekin, Tugrul Okay, Fatih Bayrak, Bülent Mutlu

chapter 21|10 pages

End-stage left ventricular failure: potential catheter-based therapeutic strategies

ByEmerson C Perin, Guilherme V Silva, Pilar Jimenez-Quevedo

chapter 22|8 pages

Massive pulmonary embolism: the potential of catheter-based strategies

ByPhillip T Zeni Jr

chapter 23|22 pages

Large thrombus burden, slow-flow, no-reflow, and distal embolization

Jose A Silva and Christopher J White

chapter 24|10 pages

The role of interventional cardiology in functional coronary stenosis Pedro A Lemos, and Antonio Esteves Filho

Eulógio E Martinez, Nestor F. Mercado, Pedro A Lemos, and Antonio Esteves Filho
ByEulógio E Martinez, Nestor F Mercado

chapter 25|12 pages

Complications of drug-eluting stents: thrombosis and restenosis

ByJ Eduardo Sousa, Luiz Alberto Mattos

chapter 26|16 pages

Coronary interventions in patients with antiplatelet therapy resistance

Dominick J Angiolillo and Marco A Costa